Viemed Healthcare Reports Q4 Revenue of $76.18M, Net Income $5.82M
Summary
Viemed Healthcare has released its fourth-quarter financial results, reporting revenue of $76.181 million, gross profit of $44.103 million, and net income of $5.816 million. These figures provide the market with the company's latest operational performance metrics. While the brief report does not include comparisons to analyst estimates or prior periods, these core financial results are critical for traders to update their valuation models and assess the company's trajectory. Investors will now await the full earnings call and detailed report for management commentary and forward-looking guidance.
At the time of this announcement, VMD was trading at $9.08 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $345.2M. The 52-week trading range was $5.93 to $9.20. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.